IntoCell Enters into Development and License Option Agreement with ADC Therapeutics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/27/2026

1. NVDA
2. USO
3. BSP
4. MPLT
5. CAPR
6. SPY
7. XFLT
8. HCA
9. ITG
10. CHTR

Go back to IntoCell Enters into Development and License Option Agreement with ADC Therapeutics
ADC TELECOMM (NYSE: ADCT) Delayed: 1.14 -0.01 (0.87%)
Previous Close $1.15    52 Week High $12.76 
Open $1.18    52 Week Low $5.18 
Day High $1.21    P/E 1.46 
Day Low $1.12    EPS $0.78 
Volume 787,747